Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
University of Southern California, Los Angeles, California University of California, San Diego, San Diego, California University of California, San Francisco, California University of Miami, Miami, Florida Northwell Health, Lake Success, New York